Page last updated: 2024-11-05

butobarbital

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

butobarbital: Butobarbital should be distinguished from Butabarbital (a synonym for Secbutabarbital) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6473
CHEMBL ID404422
CHEBI ID134884
SCHEMBL ID44262
MeSH IDM0089832

Synonyms (56)

Synonym
2,4,6(1h,3h,5h)-pyrimidinetrione, 5-butyl-5-ethyl-
wln: t6vmvmv fhj f4 f2
soneryl
butobarbital
nsc229336
longanoct
meonal
5-butyl-5-ethylbarbituric acid
5-ethyl-5-butylbarbituric acid
neonal
budorm
butobarbitone
butethal
2,6(1h,3h,5h)-pyrimidinetrione, 5-butyl-5-ethyl-
nsc-229336
sonerile
77-28-1
hyperbutal
butobarbitural
monodorm
barbituric acid, 5-butyl-5-ethyl-
etoval
5-ethyl-5-n-butylbarbituric acid
neonal (tn)
butobarbital (ban)
D02618
butobarbitalum
brn 0201786
einecs 201-019-9
aethylbutylbarbitursaeure
nsc 229336
5-butyl-5-ethyl-2,4,6(1h,3h,5h)-pyrimidinetrione
DB01353
CHEBI:134884
CHEMBL404422
5-butyl-5-ethyl-1,3-diazinane-2,4,6-trione
AKOS005256452
5-24-09-00161 (beilstein handbook reference)
butobarbital [inn:ban]
unii-ohz8qaw6yc
butethal [nf]
ohz8qaw6yc ,
butyl,5-ethylbarbituric acid
butabarbitol
SCHEMBL44262
butobarbital [mart.]
butethal [mi]
butobarbital [who-dd]
DTXSID70227808
STDBAQMTJLUMFW-UHFFFAOYSA-N
SR-01000883936-1
sr-01000883936
butobarbital 1.0 mg/ml in methanol
butobarbital 0.1 mg/ml in methanol
Q3395266
5-butyl-5-a currencythyl-barbitursa currencyure
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
barbituratesMembers of the class of pyrimidones consisting of pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid) and its derivatives. Largest group of the synthetic sedative/hypnotics, sharing a characteristic six-membered ring structure.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID1145374Induction of hypnotic activity in rat1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Molecular connectivity. 6. Examination of the parabolic relationship between molecular connectivity and biological activity.
AID1130945Inhibition of Arbacia egg cell division1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Correlation of biological activity and high-pressure liquid chromatographic retention index for a series of propranolol, barbiturate, and anthranilic acid analogues.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID603953In-vivo plasma to lung partition coefficients of the compound, logP(lung) in rat2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID1130944Hypnotic activity in rabbit1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Correlation of biological activity and high-pressure liquid chromatographic retention index for a series of propranolol, barbiturate, and anthranilic acid analogues.
AID1130943Octanol-water partition coefficient, log P of nonionized form of compound1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Correlation of biological activity and high-pressure liquid chromatographic retention index for a series of propranolol, barbiturate, and anthranilic acid analogues.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID311367Permeability coefficient in human skin2007Bioorganic & medicinal chemistry, Nov-15, Volume: 15, Issue:22
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
AID1145372Induction of hypnotic activity in rabbit1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Molecular connectivity. 6. Examination of the parabolic relationship between molecular connectivity and biological activity.
AID1130940Retention index of the compound by HPLC method1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Correlation of biological activity and high-pressure liquid chromatographic retention index for a series of propranolol, barbiturate, and anthranilic acid analogues.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (76.00)18.7374
1990's0 (0.00)18.2507
2000's4 (16.00)29.6817
2010's2 (8.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.79 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.04 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (11.54%)4.05%
Observational0 (0.00%)0.25%
Other23 (88.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]